The North America Inhalation Anesthesia Market would witness market growth of 8.0% CAGR during the forecast period (2022-2028).
Inhaled anesthetics act by increasing signals to chloride channels (GABA receptors) and potassium channels while suppressing neurotransmission pathways in the central nervous system. Acetylcholine, muscarinic and nicotinic receptors, glutamate or NMDA receptors, and serotonin are all involved in these pathways (5-HT receptors). Inhalation agents are also divided into two categories: volatile and non-volatile.
Isoflurane, desflurane, and sevoflurane, all lower blood pressure via lowering vascular resistance in the body. These drugs retain cardiac output for the most part, but cardiac depression can occur when they're taken with other IV drugs or in patients with acute cardiogenic shock. Rapid dosing of desflurane has been documented to cause hypertension and tachycardia.
In 2021, total health spending in Canada is expected to have hit a new high of over $308 billion, or $8,019 per person. Following a peak of 13.7 percent in 2020, health spending is expected to account for 12.7 percent of Canada's gross domestic product (GDP) in 2021. Due to pandemic response spending, total health expenditure in Canada increased by 12.8 percent in 2020. Prior to the pandemic, health spending increased at a rate of 4% per year on average from 2015 to 2019. Hospitals (25%) will continue to account for the highest percentage of health dollars (more than 50% of total health spending) in 2021, followed by drugs (14%), and physicians (13%). COVID-19 Response Funding, a new budget category, accounts for 7% of total health spending, which comprises federal direct and provincial/territorial government–sector spending.
In 2018, there were 1,708,921 new cancer cases reported in the United States and 599,265 cancer-related deaths. There were 436 new cancer cases reported for every 100,000 people, with 149 people dying from cancer. The most recent year for which incidence data is available is 2018. Thus, the North American region is expected to show high demand for inhalation anesthesia in the near future due to these conditions.
The US market dominated the North America Inhalation Anesthesia Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $486.2 Million by 2028. The Canada market is experiencing a CAGR of 10.5% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 9.5% during (2022 - 2028).
Based on Drug, the market is segmented into Sevoflurane, Desflurane, Isoflurane, and Others. Based on Application, the market is segmented into Maintenance and Induction. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Inhalation Anesthesia Market is Estimated to reach $1.9 Billion by 2028, at a CAGR of 8.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis AG, Piramal Enterprises Limited, Hikma Pharmaceuticals PLC, Fresenius SE & Co. KGaA, Baxter International, Inc., AbbVie, Inc., Halocarbon Products Corporation, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lunan Pharmaceutical Group Co., Ltd., and Troikaa Pharmaceuticals Limited.
Scope of the Study
Market Segments Covered in the Report:
By Drug
- Sevoflurane
- Desflurane
- Isoflurane
- Others
By Application
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Novartis AG
- Piramal Enterprises Limited
- Hikma Pharmaceuticals PLC
- Fresenius SE & Co. KGaA
- Baxter International, Inc.
- AbbVie, Inc.
- Halocarbon Products Corporation
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Lunan Pharmaceutical Group Co., Ltd.
- Troikaa Pharmaceuticals Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Inhalation Anesthesia Market, by Drug
1.4.2 North America Inhalation Anesthesia Market, by Application
1.4.3 North America Inhalation Anesthesia Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Inhalation Anesthesia Market by Drug
3.1 North America Sevoflurane Market by Country
3.2 North America Desflurane Market by Country
3.3 North America Isoflurane Market by Country
3.4 North America Others Market by Country
Chapter 4. North America Inhalation Anesthesia Market by Application
4.1 North America Maintenance Market by Country
4.2 North America Induction Market by Country
Chapter 5. North America Inhalation Anesthesia Market by Country
5.1 US Inhalation Anesthesia Market
5.1.1 US Inhalation Anesthesia Market by Drug
5.1.2 US Inhalation Anesthesia Market by Application
5.2 Canada Inhalation Anesthesia Market
5.2.1 Canada Inhalation Anesthesia Market by Drug
5.2.2 Canada Inhalation Anesthesia Market by Application
5.3 Mexico Inhalation Anesthesia Market
5.3.1 Mexico Inhalation Anesthesia Market by Drug
5.3.2 Mexico Inhalation Anesthesia Market by Application
5.4 Rest of North America Inhalation Anesthesia Market
5.4.1 Rest of North America Inhalation Anesthesia Market by Drug
5.4.2 Rest of North America Inhalation Anesthesia Market by Application
Chapter 6. Company Profiles
6.1 Novartis AG
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.2 Piramal Enterprises Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Hikma Pharmaceuticals PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 Fresenius SE & Co. KGaA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Baxter International, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals and Trials:
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Halocarbon Products Corporation
6.7.1 Company Overview
6.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
6.8.1 Company Overview
6.9 Lunan Pharmaceutical Group Co., Ltd.
6.9.1 Company Overview
6.10. Troikaa Pharmaceuticals Limited
6.10.1 Company Overview
TABLE 1 North America Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 2 North America Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 3 North America Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 4 North America Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 5 North America Sevoflurane Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Sevoflurane Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Desflurane Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Desflurane Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Isoflurane Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Isoflurane Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 14 North America Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 15 North America Maintenance Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Maintenance Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Induction Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Induction Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Inhalation Anesthesia Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Inhalation Anesthesia Market by Country, 2022 - 2028, USD Million
TABLE 21 US Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 22 US Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 23 US Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 24 US Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 25 US Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 26 US Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 27 Canada Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 28 Canada Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 29 Canada Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 30 Canada Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 31 Canada Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 32 Canada Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 33 Mexico Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 34 Mexico Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 35 Mexico Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 36 Mexico Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 37 Mexico Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 38 Mexico Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 39 Rest of North America Inhalation Anesthesia Market, 2018 - 2021, USD Million
TABLE 40 Rest of North America Inhalation Anesthesia Market, 2022 - 2028, USD Million
TABLE 41 Rest of North America Inhalation Anesthesia Market by Drug, 2018 - 2021, USD Million
TABLE 42 Rest of North America Inhalation Anesthesia Market by Drug, 2022 - 2028, USD Million
TABLE 43 Rest of North America Inhalation Anesthesia Market by Application, 2018 - 2021, USD Million
TABLE 44 Rest of North America Inhalation Anesthesia Market by Application, 2022 - 2028, USD Million
TABLE 45 Key Information – Novartis AG
TABLE 46 Key Information – Piramal Enterprises Limited
TABLE 47 Key Information – Hikma Pharmaceuticals PLC
TABLE 48 key information – Fresenius SE & Co. KGaA
TABLE 49 Key Information – Baxter International, Inc.
TABLE 50 Key information – AbbVie, Inc.
TABLE 51 Key Information – Halocarbon Products Corporation
TABLE 52 Key Information – Jiangsu Hengrui Pharmaceuticals Co., Ltd.
TABLE 53 Key Information – Lunan Pharmaceutical Group Co., Ltd.
TABLE 54 key Information – Troikaa Pharmaceuticals Limited
List of Figures
FIG 1 Methodology for the research